Outlook Therapeutics received a positive CHMP opinion from the European Medicines Agency for bevacizumab. That is a big deal since the EU is what? 15x/20X bigger than the UK. initially, their stock went up 35% now they are trading at the same level as before the positive recommendation.
NWBO will not gain more than a dime if our "brilliant" CEO Linda has not arranged non dilutive cash income for NWBO.